Condition: Haemolyses and Related Conditions · Sponsor: Sun Yat-sen University
The investigators are registering all HD patients at recruited hospitals and developing a HD database in China. Patients will be follow-up every 3 months, and both baseline and follow-up information will be entered into the registration system. The patient survival, technical survival, patency rate of access, quality of life and residual renal function for HD patients will be compared using the HD database.
This description comes directly from the study's public registry record.
Xueqing Yu, M.D. & Ph.D. · yuxq@mail.sysu.edu.cn
Xunhua Zheng, M.D. & Ph.D. · wilson_zxh@126.com
Always discuss trial participation with your own doctor first.
| The 1st Affiliated Hospital, Sun Yet-sen University | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03001921